News & Events

Sunshine Heart, Inc. (ASX: SHC), a global medical device company focused on innovative technologies for advanced heart failure, announced that on Friday, 30 April Pennsylvania State University successfully completed an implant of the Company’s C- PulseTM heart assist system in a patient under a clinical trial approved by the US Food and Drug Administration (FDA). This patient, whose progress is as expected, is the first implanted at Pennsylvania State University and the sixth patient to be treated with the C-Pulse heart assist system.